Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-03 4:59 pm Sale |
2023-07-21 | 13D | Aceragen, Inc. ACGN |
Pillar Pharmaceuticals 6 L.P. | 81,187 1.000% |
-655,295 (-88.98%) |
Filing History |
| 2023-07-17 07:30 am Sale |
2023-07-13 | 13D | Aceragen, Inc. ACGN |
Pillar Pharmaceuticals 6 L.P. | 736,482 8.700% |
-92,639 (-11.17%) |
Filing History |
| 2023-04-10 4:40 pm Sale |
2023-04-07 | 13D | Aceragen, Inc. ACGN |
Pillar Pharmaceuticals 6 L.P. | 829,121 9.500% |
-178,795 (-17.74%) |
Filing History |
| 2023-03-28 11:16 am Purchase |
2022-09-28 | 13D | Aceragen, Inc. ACGN |
Chopra Atul | 1,469,482 17.400% |
1,469,482 (New Position) |
Filing History |
| 2023-02-14 4:39 pm Purchase |
2023-02-14 | 13G | Aceragen, Inc. ACGN |
Castellina Ventures Ltd. | 276,999 3.300% |
276,999 (New Position) |
Filing History |
| 2023-01-30 4:30 pm Purchase |
2023-01-17 | 13D | Aceragen, Inc. ACGN |
Pillar Pharmaceuticals 6 L.P. | 1,007,916 11.350% |
1,007,916 (New Position) |
Filing History |
| 2023-01-18 4:54 pm Purchase |
2023-01-17 | 13D | Idera Pharmaceuticals, Inc. IDRA |
NovaQuest Co-Investment Fund XV L.P. | 909,326 9.700% |
909,326 (New Position) |
Filing History |
| 2022-10-05 4:35 pm Unchanged |
2022-09-27 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
0 (Unchanged) |
Filing History |
| 2022-06-30 5:58 pm Unchanged |
2022-06-30 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
0 (Unchanged) |
Filing History |
| 2022-06-24 4:54 pm Unchanged |
2022-06-09 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
0 (Unchanged) |
Filing History |
| 2022-06-07 4:36 pm Purchase |
2022-05-18 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Castellina Ventures Ltd. | 329,529 5.300% |
70,706 (+27.32%) |
Filing History |
| 2022-02-08 1:31 pm Purchase |
2021-12-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Castellina Ventures Ltd. | 258,824 4.200% |
2,768 (+1.08%) |
Filing History |
| 2021-06-07 5:25 pm Sale |
2021-06-01 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
-188 (-0.01%) |
Filing History |
| 2021-04-09 5:14 pm Sale |
2021-03-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Baker Bros. Advisors LP | 245,702 4.900% |
-300,335 (-55.00%) |
Filing History |
| 2021-03-31 9:02 pm Sale |
2021-03-18 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,016,025 19.900% |
-202,026 (-9.11%) |
Filing History |
| 2021-02-12 3:45 pm Sale |
2020-12-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Castellina Ventures Ltd. | 256,055 6.200% |
-8,455 (-3.20%) |
Filing History |
| 2021-01-29 4:38 pm Sale |
2020-12-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Baker Bros. Advisors LP | 546,037 12.100% |
-6,446 (-1.17%) |
Filing History |
| 2020-12-30 09:16 am Purchase |
2020-12-11 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,218,050 19.900% |
2,218,050 (New Position) |
Filing History |
| 2020-08-17 4:30 pm Purchase |
2020-07-13 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals I LP | 1,743,774 19.900% |
1,007,996 (+137.00%) |
Filing History |
| 2020-05-06 9:59 pm Purchase |
2020-04-07 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals I LP | 735,777 18.600% |
333,633 (+82.96%) |
Filing History |